These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37813566)

  • 1. Female advantage in neoadjuvant pancreatic cancer therapy: is it down to macrophages?
    Michl P; Roth L
    Gut; 2024 Jan; 73(2):214-215. PubMed ID: 37813566
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant therapy for pancreatic cancer.
    Vinciguerra V
    Oncology (Williston Park); 2011 Feb; 25(2):192-3. PubMed ID: 21456392
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy for resectable pancreatic cancer].
    Unno M
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(4):297-301. PubMed ID: 32281569
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neoadjuvant and adjuvant treatment of pancreatic cancer].
    Springfeld C; Hackert T; Jäger D; Büchler MW; Neoptolemos JP
    Chirurg; 2020 Aug; 91(8):636-641. PubMed ID: 32300820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of neoadjuvant therapy on the perioperative complications of pancreatic cancer].
    Shi S; Yu XJ
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(10):708-711. PubMed ID: 33721948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
    Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
    Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative adjuvant chemotherapy for resectable pancreatic cancer].
    Uesaka K
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(4):308-312. PubMed ID: 32281571
    [No Abstract]   [Full Text] [Related]  

  • 8. [Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].
    Seufferlein T; Michalski C
    Chirurg; 2022 May; 93(5):441-445. PubMed ID: 35376964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer.
    Keedy VL; Berlin J
    Curr Treat Options Oncol; 2006 Sep; 7(5):381-8. PubMed ID: 16904055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).
    Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA
    BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A commentary on 'Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study'.
    Zhong F; Xieb C; Peng X; Luo J; Yang H
    Int J Surg; 2024 Mar; 110(3):1331-1332. PubMed ID: 38051933
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.
    van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
    JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regional chemotherapy for pancreatic cancer].
    Tarazov PG
    Vopr Onkol; 2003; 49(2):139-44. PubMed ID: 12785192
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant Chemotherapy Is Not Guided by Pathologic Treatment Effect After Neoadjuvant Chemotherapy in Pancreatic Cancer.
    Gleeson EM; Leigh N; Golas BJ; Magge D; Sarpel U; Hiotis SP; Labow DM; Pintova S; Cohen NA
    Pancreas; 2021 Sep; 50(8):1163-1168. PubMed ID: 34714279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer].
    Scheufele F; Friess H
    Chirurg; 2020 May; 91(5):391-395. PubMed ID: 31965198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and neoadjuvant approaches in pancreatic cancer.
    Conroy T; Lambert A; Ducreux M
    Curr Opin Oncol; 2023 Jul; 35(4):326-333. PubMed ID: 37222189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Adjuvant Therapy in Patients with Pancreatic Cancer Who Underwent Neoadjuvant Therapy.
    Kurahara H; Mataki Y; Idichi T; Iino S; Kawasaki Y; Arigami T; Mori S; Sasaki K; Shinchi H; Ohtsuka T
    Ann Surg Oncol; 2021 Oct; 28(11):6238-6245. PubMed ID: 33606140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
    Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy in pancreatic cancer].
    Láng I
    Orv Hetil; 2004 Feb; 145(5):239-42. PubMed ID: 15024936
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.